Concepedia

Melinda M. Mulvihill

MM

22

Publications

1.6K

Citations

19

H-Index

2009

Active since

Affiliations

University of California, Berkeley(Current)

WuXi AppTec (China)

Roche (Switzerland)

Scripps Research Institute

Genesys (United States)

Melinda M. Mulvihill is an author at University of California, Berkeley specializing in medicine, biochemistry, and cell biology.

ORCID

Top concepts

Publications per year

2009–2024

22

Publications

22

Ether lipid generating enzyme AGPS alters the balance of structural and signaling lipids to fuel cancer pathogenicity

Daniel I. Benjamin, Alyssa J. Cozzo, Xiao‐Dan Ji et al. · Proceedings of the National Academy of Sciences · 2013 · 232 citations · Full text

Antibody Conjugation of a Chimeric BET Degrader Enables <i>in vivo</i> Activity

Thomas H. Pillow, Pragya Adhikari, Robert A. Blake et al. · ChemMedChem · 2019 · 178 citations

Antibody-Mediated Delivery of Chimeric BRD4 Degraders. Part 2: Improvement of In Vitro Antiproliferation Activity and In Vivo Antitumor Efficacy

Peter S. Dragovich, Thomas H. Pillow, Robert A. Blake et al. · Journal of Medicinal Chemistry · 2021 · 159 citations

Cancer cells incorporate and remodel exogenous palmitate into structural and oncogenic signaling lipids

Sharon M. Louie, Lindsay S. Roberts, Melinda M. Mulvihill et al. · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · 2013 · 148 citations · Full text

, , +11

Antibody-Mediated Delivery of Chimeric BRD4 Degraders. Part 1: Exploration of Antibody Linker, Payload Loading, and Payload Molecular Properties

Peter S. Dragovich, Thomas H. Pillow, Robert A. Blake et al. · Journal of Medicinal Chemistry · 2021 · 140 citations

Rows per page

1–5 of 22